KRAS and colorectal carcinoma: Although the KRAS mutation is believed to be an early event in the carcinogenesis of CRC [23] and it has been demonstrated that the KRAS mutational status is highly concordant between primary tumors and related metastases [14,15,24-28], some recent studies have produced contradictory results in regards to the KRAS mutational status [11,29-31].